Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has repurchased 140,777 of its ordinary shares between April 7th and April 10th, 2026, as part of its $250 million share repurchase program. These shares were bought on the London Stock Exchange for a volume-weighted average price of approximately 1,292.41 pence per share, with the lowest price paid being 1,273.00 pence and the highest 1,317.00 pence. The company intends to cancel these repurchased shares. Since the program's inception on February 26th, 2026, Hikma has acquired a total of 4,134,901 shares for £51.6 million, leaving it with 12,833,233 shares in treasury and 217,751,552 shares in issue.

Disclaimer*

UK 100

Latest directors dealings